ClinicalTrials.gg
CompletedNCT02444715CAPSYSUpdated Feb 18, 2016Results posted

Computer-Aided Prevention System

An interventional study of Standard care and CAPSYS in Cerebrovascular Diseases, Stroke and Cardiovascular Diseases, sponsored by Lübomira Spassova. Completed. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2016-02-18.

Sponsored by Lübomira Spassova · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
94
Allocation
Randomized
Ages
20 Years and older
Sex
All
01

Study summary

Stroke is one of the most frequent and life-threatening diseases in Europe. About four stroke events occur per day in Luxembourg alone, and about 30% of these patients are affected by recurrent stroke within the following five years. Thus, new methods of primary and secondary prevention are needed to better control lifestyle-related risk factors.

The development and maintenance of a healthy lifestyle (smoking cessation, healthy nutrition, moderate physical exercises etc.) is a major objective concerning the primary and secondary prevention of cerebro- and cardiovascular diseases. CAPSYS is a computer-based lifestyle coaching system developed by researchers from the Public Research Centre (CRP) Henri Tudor in Luxembourg in collaboration with neurologists from the Centre Hospitalier de Luxembourg (CHL), which aims at supporting patients in performing appropriate behavior changes in order to minimize their individual risk factors. Patients can access CAPSYS by dialing a local-rate telephone number and answer to a set of previously known questions concerning their current nutrition, physical activity, blood pressure, smoking etc. In an interactive voice response approach, questions are issued by the system in natural language using text-to-speech, and the patient can provide the required values using the phone keypad. Based on the gathered values for each patient, the system automatically generates personalized verbal feedback at runtime and presents it to the patient during the phone dialog. Depending on the individual development of the patient's risk factors, the system feedback can contain advice for improvement, praise for healthy behavior and motivation to pursue a certain goal.

The user acceptance and effectiveness of the CAPSYS system is evaluated in a six-month randomized controlled study with participants recruited at CHL's neurology department.

02

Conditions studied

  • Cerebrovascular Diseases
  • Stroke
  • Cardiovascular Diseases
  • CVD Risk Factors

Keywords

  • Lifestyle coaching
  • Phone-based system
  • CVD prevention
  • Patient-centered decision support
03

In context

Cerebrovascular Disorders

385 studies on the registry are indexed under Cerebrovascular Disorders; 129 are open to participants now.

This study's enrollment of 94 is below the median of 109 across 224 interventional studies indexed under Cerebrovascular Disorders.

Browse Cerebrovascular Disorders studies →

Lead sponsor

This is the only study on the registry with Lübomira Spassova as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • At high risk of stroke:

    • Already suffered a stroke or Transient Ischemic Attack (TIA) or
    • At least two risk factors for stroke:

      • High blood pressure
      • Overweight
      • Low physical activity
      • Smoking
      • Unhealthy diet

Exclusion criteria

Exclusion Criteria:

  • Inability to fill out or to understand the informed consent
  • No signed informed consent
  • Dementia
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
94 participants (actual)

Study arms

  • Active comparator
    Standard care (SC)

    Behavioral: Standard care

  • Experimental
    Interventional care (IC)

    Behavioral: CAPSYS

Interventions

  • BehavioralStandard care

    Participants receive only the usual care including blood analyses, blood pressure controls and individual advice on healthy lifestyle during the outpatient treatment given by the neurologist, by the general practitioner and by other physicians.

  • BehavioralCAPSYS

    In addition to the usual care, patients are asked to call the CAPSYS system twice a week.

06

What researchers measure

Primary outcomes

  1. Change in Systolic Blood Pressure

    Time frame: baseline and 6 months

  2. Change in HDL Level

    Time frame: baseline and 6 months

  3. Change in LDL Level

    Time frame: baseline and 6 months

  4. Change in Triglyceride Level

    Time frame: baseline and 6 months

  5. Change in HbA1c Level

    Time frame: baseline and 6 months

  6. Change in Glycaemia Level

    Time frame: baseline and 6 months

  7. Change in BMI Value

    Time frame: baseline and 6 months

Secondary outcomes

  1. Change in Fruits and Vegetables Consumption

    Self-reported weekly portions of fruits and vegetables consumption (During the recruiting interview, participants were instructed in estimating the size of a portion of fruits or vegetables and they were provided an information booklet on this topic.)

    Time frame: baseline and 6 months

  2. Change in Whole Grain Food Consumption

    Self-reported weekly portions of whole grain food consumption (During the recruiting interview, participants were instructed in estimating the size of a portion of whole grain food and they were provided an information booklet on this topic.)

    Time frame: baseline and 6 months

  3. Change in Sweets Consumption

    Self-reported weekly portions of sweets consumption (During the recruiting interview, participants were instructed in estimating the size of a portion of sweets and they were provided an information booklet on this topic.)

    Time frame: baseline and 6 months

  4. Change in Duration of Physical Activity

    Self-reported weekly duration of physical activity of medium or high intensity

    Time frame: baseline and 6 months

  5. Change in Quality of Life

    The QoL was measured using the standardised EQ-5D-5L instrument provided by the EuroQol Group. In this context, the health value was specified by the participants on a subjective scale ranging from 0 ("The worst health you can imagine") to 100 ("The best health you can imagine").

    Time frame: baseline and 6 months

Other outcomes

  1. Usability: SUS Score

    The usability of the intervention was assessed based on the standardised System Usability Scale (SUS). SUS scores were not collected in the SC group because the SC participants were not using CAPSYS and hence were not able to assess its usability. The System Usability Scale (SUS) provides a "quick and dirty", reliable tool for measuring the usability. It consists of a 10 item questionnaire with five response options for respondents; from Strongly agree to Strongly disagree. Originally created by John Brooke in 1986, it allows to evaluate a wide variety of products and services, including hardware, software, mobile devices, websites and applications. The total SUS score computed based on the responses provided to each of the 10 items can range from 0 (worst) to 100 (best). Based on research, a SUS score above a 68 would be considered above average and anything below 68 is below average.

    Time frame: 6 months

07

Results

Posted Aug 24, 2015

Participant flow

Participant flow — Overall Study
MilestoneStandard Care (SC)Interventional Care (IC)
Started4648
Completed3632
Not completed1016

Outcome measures

PrimaryChange in Systolic Blood Pressure
Time frame:
baseline and 6 months
Reported as:
Mean · mmHg
Change in Systolic Blood Pressure
mmHgStandard Care (SC)Interventional Care (IC)
Change in Systolic Blood Pressure0.19 ± 21.34-9 ± 21.37
Statistical analysis
  • Standard Care (SC) · t-test, 2 sided · p = 0.96
  • Interventional Care (IC) · t-test, 2 sided · p = 0.03
PrimaryChange in HDL Level
Time frame:
baseline and 6 months
Reported as:
Median · mg/dl
Change in HDL Level
mg/dlStandard Care (SC)Interventional Care (IC)
Change in HDL Level1 (-5 to 7)-2 (-7 to 4)
Statistical analysis
  • Standard Care (SC) · Wilcoxon (Mann-Whitney) · p = 0.53
  • Interventional Care (IC) · Wilcoxon (Mann-Whitney) · p = 0.44
PrimaryChange in LDL Level
Time frame:
baseline and 6 months
Reported as:
Median · mg/dl
Change in LDL Level
mg/dlStandard Care (SC)Interventional Care (IC)
Change in LDL Level-1 (-17 to 10)-6 (-16 to 3)
Statistical analysis
  • Standard Care (SC) · Wilcoxon (Mann-Whitney) · p = 0.76
  • Interventional Care (IC) · Wilcoxon (Mann-Whitney) · p = 0.04
PrimaryChange in Triglyceride Level
Time frame:
baseline and 6 months
Reported as:
Median · mg/dl
Change in Triglyceride Level
mg/dlStandard Care (SC)Interventional Care (IC)
Change in Triglyceride Level-1 (-33.25 to 18)-11 (-37.5 to 10.25)
Statistical analysis
  • Standard Care (SC) · Wilcoxon (Mann-Whitney) · p = 0.39
  • Interventional Care (IC) · Wilcoxon (Mann-Whitney) · p = 0.04
PrimaryChange in HbA1c Level
Time frame:
baseline and 6 months
Reported as:
Median · percent HbA1c
Change in HbA1c Level
percent HbA1cStandard Care (SC)Interventional Care (IC)
Change in HbA1c Level-0.1 (-0.2 to 0.2)-0.1 (-0.2 to 0)
Statistical analysis
  • Standard Care (SC) · Wilcoxon (Mann-Whitney) · p = 0.92
  • Interventional Care (IC) · Wilcoxon (Mann-Whitney) · p = 0.37
PrimaryChange in Glycaemia Level
Time frame:
baseline and 6 months
Reported as:
Median · mg/dl
Change in Glycaemia Level
mg/dlStandard Care (SC)Interventional Care (IC)
Change in Glycaemia Level-0.5 (-8.25 to 6)-2 (-7.5 to 2.5)
Statistical analysis
  • Standard Care (SC) · Wilcoxon (Mann-Whitney) · p = 0.78
  • Interventional Care (IC) · Wilcoxon (Mann-Whitney) · p = 0.19
PrimaryChange in BMI Value
Time frame:
baseline and 6 months
Reported as:
Mean · kg/m^2
Change in BMI Value
kg/m^2Standard Care (SC)Interventional Care (IC)
Change in BMI Value0.05 ± 1.61-0.26 ± 1.3
Statistical analysis
  • Standard Care (SC) · t-test, 2 sided · p = 0.9
  • Interventional Care (IC) · t-test, 2 sided · p = 0.43
SecondaryChange in Fruits and Vegetables Consumption

Self-reported weekly portions of fruits and vegetables consumption (During the recruiting interview, participants were instructed in estimating the size of a portion of fruits or vegetables and they were provided an information booklet on this topic.)

Time frame:
baseline and 6 months
Reported as:
Median · portions
Change in Fruits and Vegetables Consumption
portionsStandard Care (SC)Interventional Care (IC)
Change in Fruits and Vegetables Consumption0 (-7 to 7)3.5 (-3.25 to 11.75)
Statistical analysis
  • Standard Care (SC) · Wilcoxon (Mann-Whitney) · p = 0.67
  • Interventional Care (IC) · Wilcoxon (Mann-Whitney) · p = 0.04
SecondaryChange in Whole Grain Food Consumption

Self-reported weekly portions of whole grain food consumption (During the recruiting interview, participants were instructed in estimating the size of a portion of whole grain food and they were provided an information booklet on this topic.)

Time frame:
baseline and 6 months
Reported as:
Median · portions
Change in Whole Grain Food Consumption
portionsStandard Care (SC)Interventional Care (IC)
Change in Whole Grain Food Consumption0 (-4 to 3)1 (-0.25 to 7)
Statistical analysis
  • Standard Care (SC) · Wilcoxon (Mann-Whitney) · p = 0.26
  • Interventional Care (IC) · Wilcoxon (Mann-Whitney) · p = 0.07
SecondaryChange in Sweets Consumption

Self-reported weekly portions of sweets consumption (During the recruiting interview, participants were instructed in estimating the size of a portion of sweets and they were provided an information booklet on this topic.)

Time frame:
baseline and 6 months
Reported as:
Median · portions
Change in Sweets Consumption
portionsStandard Care (SC)Interventional Care (IC)
Change in Sweets Consumption0 (0 to 1)0 (0 to 2)
Statistical analysis
  • Standard Care (SC) · Wilcoxon (Mann-Whitney) · p = 0.06
  • Interventional Care (IC) · Wilcoxon (Mann-Whitney) · p = 0.04
SecondaryChange in Duration of Physical Activity

Self-reported weekly duration of physical activity of medium or high intensity

Time frame:
baseline and 6 months
Reported as:
Median · minutes
Change in Duration of Physical Activity
minutesStandard Care (SC)Interventional Care (IC)
medium intensity0 (-60 to 135)0 (-60 to 112.5)
high intensity0 (-120 to 15)0 (-45 to 30)
Statistical analysis
  • Standard Care (SC) · Wilcoxon (Mann-Whitney) · p = 0.37
  • Interventional Care (IC) · Wilcoxon (Mann-Whitney) · p = 0.34
  • Standard Care (SC) · Wilcoxon (Mann-Whitney) · p = 0.37
  • Interventional Care (IC) · Wilcoxon (Mann-Whitney) · p = 0.59
SecondaryChange in Quality of Life

The QoL was measured using the standardised EQ-5D-5L instrument provided by the EuroQol Group. In this context, the health value was specified by the participants on a subjective scale ranging from 0 ("The worst health you can imagine") to 100 ("The best health you can imagine").

Time frame:
baseline and 6 months
Reported as:
Median · units on a scale (health value)
Change in Quality of Life
units on a scale (health value)Standard Care (SC)Interventional Care (IC)
Change in Quality of Life0 (-6.25 to 10)0 (-0.25 to 5)
Statistical analysis
  • Standard Care (SC) · Wilcoxon (Mann-Whitney) · p = 0.64
  • Interventional Care (IC) · Wilcoxon (Mann-Whitney) · p = 0.14
Other pre-specifiedUsability: SUS Score

The usability of the intervention was assessed based on the standardised System Usability Scale (SUS). SUS scores were not collected in the SC group because the SC participants were not using CAPSYS and hence were not able to assess its usability. The System Usability Scale (SUS) provides a "quick and dirty", reliable tool for measuring the usability. It consists of a 10 item questionnaire with five response options for respondents; from Strongly agree to Strongly disagree. Originally created by John Brooke in 1986, it allows to evaluate a wide variety of products and services, including hardware, software, mobile devices, websites and applications. The total SUS score computed based on the responses provided to each of the 10 items can range from 0 (worst) to 100 (best). Based on research, a SUS score above a 68 would be considered above average and anything below 68 is below average.

Time frame:
6 months
Reported as:
Mean · units on a scale (total SUS score)
Usability: SUS Score
units on a scale (total SUS score)Interventional Care (IC)
Usability: SUS Score80.1 ± 16.22

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Standard Care (SC)—0/46 (0%)0/46 (0%)
Interventional Care (IC)—0/48 (0%)0/48 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Standard Care (SC)Interventional Care (IC)Total
Mean59.6 ± 12.160.7 ± 11.360.2 ± 11.6
Sex: Female, Male
Sex: Female, Male(Participants)Standard Care (SC)Interventional Care (IC)Total
Female171431
Male293463
08

Study locations

No study locations are listed for this record.

09

References and documents

Publications

  • Spassova L, Vittore D, Droste D, Rosch N. Automated lifestyle coaching for cerebro-cardiovascular disease prevention. Stud Health Technol Inform. 2013;190:234-6. PubMed 23823433 ↗
  • Crocker TF, Brown L, Lam N, Wray F, Knapp P, Forster A. Information provision for stroke survivors and their carers. Cochrane Database Syst Rev. 2021 Nov 23;11(11):CD001919. doi: 10.1002/14651858.CD001919.pub4. PubMed 34813082 ↗
  • Spassova L, Vittore D, Droste DW, Rosch N. Randomised controlled trial to evaluate the efficacy and usability of a computerised phone-based lifestyle coaching system for primary and secondary prevention of stroke. BMC Neurol. 2016 Feb 9;16:22. doi: 10.1186/s12883-016-0540-4. PubMed 26861865 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 18, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02444715
Lead sponsor
Lübomira Spassova
Collaborators
Centre Hospitalier du Luxembourg
Responsible party
Lübomira Spassova (Dr.-Ing., Luxembourg Institute of Science and Technology) — Sponsor-investigator
First posted
May 14, 2015
Start date
Jan 2013
Primary completion
Aug 2014
Completion
Aug 2014
Results posted
Aug 24, 2015
Last update
Feb 18, 2016

Study contacts

Lübomira Spassova, Dr.-Ing.
study chair · Luxembourg Institute of Science and Technology
Debora Vittore
study chair · Centre Hospitalier de Luxembourg (CHL)
Dirk W Droste, Prof. Dr.
principal investigator · Centre Hospitalier de Luxembourg (CHL)
Norbert Rösch, Prof. Dr.
study director · University of Applied Sciences Kaiserslautern

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion